| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |